OXYGENTA PHARMACEUTICAL
Back to Income Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Operating Profit History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹-9.70 Cr | ₹-7.12 Cr | ₹147,599 Cr | ₹3.84 Cr | ₹-7.87 Cr |
What is the latest Operating Profit of OXYGENTA PHARMACEUTICAL ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹-9.70 Cr |
| Mar2024 | ₹-7.12 Cr |
| Mar2023 | ₹147,599 Cr |
| Mar2022 | ₹3.84 Cr |
| Mar2021 | ₹-7.87 Cr |
How is Operating Profit of OXYGENTA PHARMACEUTICAL Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹-9.70 Cr | Negative | |
| Mar2024 | ₹-7.12 Cr | Negative | |
| Mar2023 | ₹147,599 Cr | 3,841,628.53 | |
| Mar2022 | ₹3.84 Cr | Positive | |
| Mar2021 | ₹-7.87 Cr | - | |
Compare Operating Profit of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹196.7 Cr | -1.6% | -6.7% | -36.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,591.0 Cr | 3.2% | 12.4% | 11.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹183,512.0 Cr | 1.8% | 11% | 10.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,850.0 Cr | 3.8% | 6.7% | 35.5% | Stock Analytics | |
| CIPLA | ₹113,884.0 Cr | 6.2% | 13.9% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,339.0 Cr | 5.4% | 8% | 9.1% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -1.6% |
-6.7% |
-36.3% |
| SENSEX | 0.9% |
-3.6% |
-7.3% |
You may also like the below Video Courses